Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke.
The low plasma nitric oxide concentrations and reduced vascular reactivity are considered major proatherogenic mechanisms in cardiovascular diseases. The present study aimed to assess the allelic frequency and the genotypic distribution of the Glu298Asp gene polymorphism at exon 7 of endothelial nitric oxide synthase (eNOS) gene in Turkish ischemic stroke patients compared to appropriate healthy controls, and to correlate the genetic findings with stroke subtypes. The study population included 146 (75 males, 71 females) patients with ischemic stroke which were categorized according to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) and 133 (34 males, 99 females) healthy subjects. The eNOS polymorphism was identified with a PCR followed by RFLP with the restriction enzyme BanII. Genotypes were defined as GG, GT, and TT according to the presence of the G and T alleles. In this case-control study, we did not find any significant difference in either the genotypic distribution or allelic frequency of Glu298Asp gene polymorphism between the patients and the controls. In addition, there was also no significant difference for the genotype distribution and the allelic frequency among the stroke subtypes. The results suggested the lack of the association between the Glu298Asp gene polymorphism and ischemic stroke or subtypes of ischemic stroke in the Turkish population.
Guldiken
Baburhan
B
Department of Neurology, Medical Faculty, Trakya University, Edirne, 22030, Turkey. baburhan@hotmail.com
Sipahi
Tammam
T
Guldiken
Sibel
S
Ustundag
Sedat
S
Budak
Metin
M
Turgut
Nilda
N
Ozkan
Hulya
H
D019943:Amino Acid Substitution; D016022:Case-Control Studies; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D052250:Nitric Oxide Synthase Type III / Q000235:genetics*; D019683:Penetrance; D011110:Polymorphism, Genetic; D020521:Stroke / Q000201:enzymology* / Q000235:genetics; D014421:Turkey
C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III
Cerebrovasc Dis. 1998 Sep-Oct;8(5):278-88
9712926
Hypertension. 1998 Sep;32(3):521-6
9740620
Am J Epidemiol. 2006 Nov 15;164(10):921-35
17018701
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s11-6
18174453
J Am Coll Cardiol. 2003 Mar 19;41(6):938-45
12651037
Stroke. 1998 Sep;29(9):1908-11
9731617
Circ Res. 2002 Jun 14;90(11):1153-8
12065317
Cardiovasc Drug Rev. 2007 Fall;25(3):280-8
17919260
Stroke. 1993 Jan;24(1):35-41
7678184
J Hypertens. 2000 Dec;18(12):1767-73
11132600
Stroke. 2000 Jul;31(7):1634-9
10884465
Free Radic Biol Med. 2007 Sep 15;43(6):987-92
17697943
Nitric Oxide. 2005 May;12(3):141-9
15797842
Brain. 2000 Sep;123 ( Pt 9):1784-812
10960044
Hypertension. 1998 Jul;32(1):3-8
9674630
Cell Mol Life Sci. 1999 Jul;55(8-9):1078-87
10442089
Hum Genet. 2007 Apr;121(2):169-78
17165044
Neurology. 1999 Jul 22;53(2):418-20
10430441
J Neurol. 2008 Jan;255(1):94-8
18080850
Stroke. 2004 Mar;35(3):654-9
14963277
J Biol Chem. 2001 Jul 13;276(28):26674-9
11331296
Am J Hematol. 2004 May;76(1):40-3
15114595
Diabetes. 2006 Jul;55(7):2140-7
16804086
Acta Neurol Scand. 2005 Jan;111(1):29-33
15595935
Clin Sci (Lond). 2005 Nov;109(5):475-81
16060860
J Hypertens. 2002 Oct;20(10):2023-7
12359981
J Clin Neurosci. 2006 Feb;13(2):224-7
16446094